AliveDx Suisse S.A. and Patho Solutions Malaysia Sdn. Bhd. have signed a distribution agreement, which will enable Patho Solutions Malaysia to distribute the MosaiQ® solution in Malaysia. The distribution agreement takes effect immediately.
AliveDx is dedicated to expanding its reach and presence across various regions and to creating clinical and economical value for clinicians, helping them to shorten the time to diagnosis. This strategic collaboration with a solid partner in Malaysia is a testimony to the company’s commitment to supporting the healthcare sector and enhancing patient care.
The MosaiQ solution simplifies workflows and creates efficiencies thanks to its multiplexing microarray assay technology. This streamlined and efficient approach offers faster and more cost-effective solutions to healthcare providers and patients alike.
“Our collaboration with Patho Solutions Malaysia marks yet another strategic move affirming our dedication to global expansion. We are eager to work with such a strong partner and support the healthcare community in Malaysia,” said Manuel O. Méndez, AliveDx’s CEO.
Patho Solutions Malaysia is a subsidiary company of UMediC Group Berhad, a reputed importer and distributor of innovative in-vitro diagnostic (IVD) and medical technology solutions in Malaysia. Their portfolio includes high-quality IVD solutions, clinical diagnostics, laboratory equipment, consumables, chemicals, and reagents.
“We are honored to collaborate with AliveDx. One of our group initiatives is to venture into the IVD business. Patho Solution Malaysia is already present in the histopathology segment, and having the AliveDx solution in our portfolio marks our desire to further expand into the immunology diagnostic segment. We believe the MosaiQ solution will enable us to provide the Malaysian healthcare sector with the latest, best-in-class technology that will have a positive impact on patients,” said Mr. Eric, CEO of Patho Solutions Malaysia and UMediC Group Berhad.
To learn more, please visit the Patho Solution Malaysia and UMediC Group Berhad websites.
